Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme ; volume:12 ; number:1 ; day:10 ; month:7 ; year:2021 ; pages:1-17 ; date:12.2021
Cancer nanotechnology ; 12, Heft 1 (10.7.2021), 1-17, 12.2021
- Creator
-
Rehman, Fawad Ur
Rauf, Mohd Ahmar
Ullah, Sajjad
Shaikh, Sana
Qambrani, Aqsa
Muhammad, Pir
Hanif, Sumaira
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12645-021-00088-6
- URN
-
urn:nbn:de:101:1-2021101620270122568054
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rehman, Fawad Ur
- Rauf, Mohd Ahmar
- Ullah, Sajjad
- Shaikh, Sana
- Qambrani, Aqsa
- Muhammad, Pir
- Hanif, Sumaira
- SpringerLink (Online service)
Other Objects (12)
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme